Explore 3 Stock Ideas & Industry Insights Download Free Report

Aquarius Surgical Technologies Inc

Company price
0.01 CAD 0.00(0%)
Last update at 2026-11-05T14:30:00Z
Market Cap
0.41M

Momentum Score

…

Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada and the United States. It offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery. The company was incorporated in 1986 and is based in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Aquarius Surgical Technologies Inc is a Canada-listed company with limited public disclosures about its operations and commercial products; publicly available filings and corporate information are sparse. Long-term growth could be driven by successful clinical validation, regulatory approvals, commercialization and partnerships common to surgical-technology firms, and investors may find exposure to potential medical-device upside while monitoring milestone progress.
Key risks include early-stage operations with uncertain or no revenue, regulatory and clinical execution risk, dependency on successful financing which could be dilutive, and limited transparency that makes assessment of competitive position difficult.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.08M
Revenue Per Share
0.00
Gross Profit TTM
0.04M
Debt / Equity
-1.04
ROE
-
Net Debt
6.41M
ROCE
-411.24%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -1.17M -0.75M -0.72M -0.86M -1.81M
Net income -1.17M -0.76M -0.72M -0.86M -1.81M
Selling general administrative 0.56M 0.59M 0.73M 0.77M 0.87M
Gross profit 0.05M 0.13M 0.08M 0.13M 0.22M
Reconciled depreciation 0.03M 0.03M 0.01M 0.05M 0.14M
Ebit - - -0.65M -0.69M -0.79M
Ebitda - - -0.52M -0.61M -0.66M
Operating income -0.86M -0.75M -0.75M -0.69M -0.79M
Interest expense 0.31M 0.29M 0.20M 0.20M 0.22M
Tax provision 0.00M 0.01M 0.00M - -
Interest income 0.30M 0.00M 0.03M 0.01M 0.01M
Net interest income -0.32M -0.26M -0.21M -0.20M 0.01M
Total revenue 0.09M 0.21M 0.20M 0.33M 0.58M
Total operating expenses 0.64M 0.69M 0.86M 1.02M 1.38M
Cost of revenue 0.04M 0.07M 0.12M 0.20M 0.37M
Total other income expense net -0.30M 0.00M 0.14M 0.03M -1.03M
Net income from continuing ops -1.17M -0.76M -0.72M -0.86M -1.81M
Net income applicable to common shares -1.17M -0.76M -0.72M -0.86M -1.81M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1.95M 0.57M 0.68M 0.89M 0.95M
Other current assets - - - 0.00M -
Total liab 7.72M 5.18M 4.53M 4.11M 3.34M
Total stockholder equity -5.77M -4.61M -3.85M -3.21M -2.39M
Common stock - 19.95M 19.95M 19.87M 19.84M
Capital stock 19.95M 19.95M 19.95M 19.87M 19.84M
Retained earnings -35.04M -33.87M -33.12M -32.39M -31.53M
Other assets - - - - -0.00M
Cash 0.01M 0.11M 0.12M 0.16M 0.15M
Total current liabilities 1.74M 1.87M 1.51M 1.65M 1.00M
Net debt 6.41M 3.85M 3.28M 3.08M 0.66M
Short term debt - 0.33M 0.19M 0.16M 0.15M
Short long term debt 0.46M 0.71M 0.47M 0.78M 0.58M
Short long term debt total - - - - 2.50M
Property plant equipment - 0.08M 0.10M 0.01M 0.30M
Total current assets 0.10M 0.19M 0.27M 0.61M 0.64M
Long term investments 1.80M 0.30M 0.30M 0.28M 0.00M
Net tangible assets - - -3.85M -3.21M -2.39M
Net receivables 0.05M 0.05M 0.08M 0.09M 0.20M
Long term debt 5.96M 3.25M 2.93M 2.46M 0.23M
Inventory 0.02M 0.02M 0.04M 0.04M 0.02M
Accounts payable 1.25M 1.14M 1.02M 0.87M 0.41M
Non current assets total 1.85M 0.38M 0.41M 0.29M 0.30M
Capital lease obligations 0.05M 0.08M 0.11M 0.00M -
Long term debt total - 3.31M 3.01M 2.46M 2.35M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -1.80M -0.00M -0.00M -0.01M -0.10M
Change to liabilities - - 0.35M 0.45M 0.09M
Total cashflows from investing activities -1.80M -0.00M 0.00M -0.01M -0.10M
Net borrowings -0.17M -0.09M -0.09M 0.15M 0.68M
Total cash from financing activities 2.08M 0.24M -0.11M 0.13M 0.59M
Change to operating activities - - 0.33M -0.04M 0.01M
Net income -1.17M -0.76M -0.72M -0.86M -1.81M
Change in cash -0.10M -0.01M -0.04M 0.01M 0.04M
Begin period cash flow 0.11M 0.12M 0.16M 0.15M 0.11M
End period cash flow 0.01M 0.11M 0.12M 0.16M 0.15M
Total cash from operating activities -0.38M -0.25M 0.08M -0.11M -0.45M
Issuance of capital stock - - - - 0.00M
Depreciation 0.03M 0.03M 0.01M 0.05M 0.14M
Other cashflows from investing activities -1.80M - - - 0.00M
Dividends paid - 0.00M 0.00M 0.00M -
Change to inventory -0.00M 0.03M 0.00M -0.02M 0.08M
Change to account receivables -0.00M 0.03M 0.01M 0.12M -0.06M
Sale purchase of stock - - - 0.00M -0.00M
Other cashflows from financing activities - -0.02M -0.02M -0.02M -0.09M
Change to netincome - - 0.11M 0.19M 1.10M
Capital expenditures 0.00M 0.00M 0.00M 0.01M 0.10M
Change in working capital 0.11M 0.19M 0.69M 0.50M 0.28M
Stock based compensation - 0.00M 0.01M 0.00M 0.02M
Other non cash items 0.30M 0.29M 0.23M 0.22M 0.31M
Free cash flow -0.38M -0.26M 0.08M -0.11M -0.51M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ASTI
Aquarius Surgical Technologies Inc
-
-%
0.01 - - 5.52 31.44 96.08 56.94
BLO
Cannabix Technologies Inc
-
-%
0.40 - - 556.83 57.80 564.68 -11.28

Profile*

Aquarius Surgical Technologies Inc

Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada and the United States. It offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery. The company was incorporated in 1986 and is based in Toronto, Canada.

89 Scollard Street, Toronto, ON, Canada, M5R 1G4

902-410-9013

Name Title Year Born
Mr. Lorne Stewart MacFarlane CEO & CFO NA
Mr. Brian Wagner Vice President of Sales for SLI US Inc. NA
Mr. Christopher H. Freeman Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…